ISIN | LU2851595392 |
---|---|
Valor Number | 136502437 |
Bloomberg Global ID | |
Fund Name | Swisscanto (LU) Equity Fund Sustainable Healthy Longevity CT |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | Swisscanto Fondsleitung AG |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The total commitments of the fund may not amount to more than 210% as a result of the use of derivatives (max. 100%) and temporary borrowing (max. 10%). |
Peculiarities |
Current Price * | 102.73 EUR | 11.11.2024 |
---|---|---|
Previous Price * | 101.75 EUR | 08.11.2024 |
52 Week High * | 102.73 EUR | 11.11.2024 |
52 Week Low * | 99.42 EUR | 06.09.2024 |
NAV * | 102.73 EUR | 11.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 71,745,222 | |
Unit/Share Assets *** | 25,289 | |
Trading Information SIX |
YTD Performance | - | - |
---|---|---|
YTD Performance (in CHF) | - | - |
1 month | +1.63% |
11.10.2024 - 11.11.2024
11.10.2024 11.11.2024 |
3 months | +2.73% |
27.08.2024 - 11.11.2024
27.08.2024 11.11.2024 |
6 months | - | - |
1 year | - | - |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | 90.68 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 3.50% | |
---|---|---|
Welltower Inc | 3.01% | |
Vertex Pharmaceuticals Inc | 2.87% | |
Sprouts Farmers Market Inc | 2.74% | |
Haleon PLC | 2.67% | |
Gilead Sciences Inc | 2.66% | |
Stryker Corp | 2.63% | |
IQVIA Holdings Inc | 2.61% | |
Tenet Healthcare Corp | 2.60% | |
BioMerieux SA | 2.57% | |
Last data update | 31.08.2024 |
TER | |
---|---|
TER date | |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 1.40% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |